Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli
U-Im Chang, Hyung Wook Kim, Seong-Heon Wie
Korean J Intern Med. 2016;31(1):145-155. Published online 2015 Dec 28 DOI: https://doi.org/10.3904/kjim.2016.31.1.145
Citations to this article as recorded by 
Economic Burden of Community-Acquired Antibiotic-Resistant Urinary Tract Infections: Systematic Review and Meta-Analysis
Nina Jiayue Zhu, Misghina Weldegiorgis, Emma Carter, Colin Brown, Alison Holmes, Paul Aylin
JMIR Public Health and Surveillance.2024; 10: e53828. CrossRef
A systematic review and meta-analysis on prevalence and antimicrobial resistance profile of Escherichia coli isolated from water in africa (2000–2021)
Tsepo Ramatla, Taole Ramaili, Kgaugelo E. Lekota, Rendani Ndou, Nthabiseng Mphuti, Carlos Bezuidenhout, Oriel Thekisoe
Heliyon.2023; 9(6): e16123. CrossRef
Urinary Tract Infections Caused by Uropathogenic Escherichia coli: Mechanisms of Infection and Treatment Options
Yang Zhou, Zuying Zhou, Lin Zheng, Zipeng Gong, Yueting Li, Yang Jin, Yong Huang, Mingyan Chi
International Journal of Molecular Sciences.2023; 24(13): 10537. CrossRef
A retrospective review of oral cephalosporins versus fluoroquinolones for the treatment of pyelonephritis
Kevin Lin, Yorgo Zahlanie, Jessica K. Ortwine, Wenjing Wei, Norman S. Mang, Bonnie C. Prokesch, Monica Cartelle Gestal
PLOS ONE.2022; 17(9): e0274194. CrossRef
Cefuroxime pharmacokinetics and pharmacodynamics for intravenous dosage regimens with 750 mg or 1500 mg doses in healthy young volunteers
Sara Thønnings, Klaus S. Jensen, Ninna B. Nielsen, Martin Skjønnemand, Dennis S. Hansen, Kai H. W. Lange, Niels Frimodt-Møller
Journal of Medical Microbiology
.2020; 69(3): 387. CrossRef
Phage Therapy as a Novel Strategy in the Treatment of Urinary Tract Infections Caused by E. Coli
Beata Zalewska-Piątek, Rafał Piątek
Antibiotics.2020; 9(6): 304. CrossRef
Oral treatment of acute pyelonephritis: when, with which antimicrobial agent and for how long?
Carlos Pigrau, Laura Escolà-Vergé
Enfermedades Infecciosas y Microbiología Clínica.2020; 38(7): 303. CrossRef
Oral treatment of acute pyelonephritis: when, with which antimicrobial agent and for how long?
Carlos Pigrau, Laura Escolà-Vergé
Enfermedades infecciosas y microbiologia clinica (English ed.).2020; 38(7): 303. CrossRef
Inappropriate empirical antibiotic therapy does not adversely affect the clinical outcomes of patients with acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales
Si-Ho Kim, Suhyun Oh, Kyungmin Huh, Sun Young Cho, Cheol-In Kang, Doo Ryeon Chung, Kyong Ran Peck
European Journal of Clinical Microbiology & Infectious Diseases.2019; 38(5): 937. CrossRef
Urine Cultures in Pyelonephritis: An Overstated Requirement
Brit Long, Alex Koyfman, Michael D. April
Annals of Emergency Medicine.2019; 74(4): 598. CrossRef
Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections
Cheol-In Kang, Jieun Kim, Dae Won Park, Baek-Nam Kim, U-Syn Ha, Seung-Ju Lee, Jeong Kyun Yeo, Seung Ki Min, Heeyoung Lee, Seong-Heon Wie
Infection & Chemotherapy.2018; 50(1): 67. CrossRef
UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies
Maria E. Terlizzi, Giorgio Gribaudo, Massimo E. Maffei
Frontiers in Microbiology.2017;[Epub] CrossRef